In this interview we discuss the GeneFx Colon test (or the ColDx assay), which can helpful identify patients with low- or high-risk stage II colon cancer.
Donna Niedzwiecki, PhD
Advertisement
Articles by Donna Niedzwiecki, PhD
Advertisement
Latest Updated Articles
Could Gene Assay Help Guide Stage II Colon Cancer Treatment?Published: September 14th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer
2
Dato-DXd Improves Survival in Recurrent Inoperable/Metastatic TNBC
3
How Will RLTs Be Integrated Into the Prostate Cancer Treatment Paradigm?
4
Intravesical Mitomycin Produces Enduring Efficacy Across NMIBC Trials
5
